Vascular smooth muscle contraction in hypertension
- PMID: 29394331
- PMCID: PMC5852517
- DOI: 10.1093/cvr/cvy023
Vascular smooth muscle contraction in hypertension
Abstract
Hypertension is a major risk factor for many common chronic diseases, such as heart failure, myocardial infarction, stroke, vascular dementia, and chronic kidney disease. Pathophysiological mechanisms contributing to the development of hypertension include increased vascular resistance, determined in large part by reduced vascular diameter due to increased vascular contraction and arterial remodelling. These processes are regulated by complex-interacting systems such as the renin-angiotensin-aldosterone system, sympathetic nervous system, immune activation, and oxidative stress, which influence vascular smooth muscle function. Vascular smooth muscle cells are highly plastic and in pathological conditions undergo phenotypic changes from a contractile to a proliferative state. Vascular smooth muscle contraction is triggered by an increase in intracellular free calcium concentration ([Ca2+]i), promoting actin-myosin cross-bridge formation. Growing evidence indicates that contraction is also regulated by calcium-independent mechanisms involving RhoA-Rho kinase, protein Kinase C and mitogen-activated protein kinase signalling, reactive oxygen species, and reorganization of the actin cytoskeleton. Activation of immune/inflammatory pathways and non-coding RNAs are also emerging as important regulators of vascular function. Vascular smooth muscle cell [Ca2+]i not only determines the contractile state but also influences activity of many calcium-dependent transcription factors and proteins thereby impacting the cellular phenotype and function. Perturbations in vascular smooth muscle cell signalling and altered function influence vascular reactivity and tone, important determinants of vascular resistance and blood pressure. Here, we discuss mechanisms regulating vascular reactivity and contraction in physiological and pathophysiological conditions and highlight some new advances in the field, focusing specifically on hypertension.
Figures
References
-
- Savoia C, Burger D, Nishigaki N, Montezano A, Touyz RM.. Angiotensin II and the vascular phenotype in hypertension. Expert Rev Mol Med 2011; 13:11–20. - PubMed
-
- Intengan HD, Schiffrin EL.. Structure and mechanical properties of resistance arteries in hypertension role of adhesion molecules and extracellular matrix determinants. Hypertension 2000; 36:312–318. - PubMed
-
- Touyz RM, Schiffrin EL.. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 2000; 52:639–672. - PubMed
-
- Endemann DH, Schiffrin EL.. Endothelial dysfunction. J Am Soc Nephrol 2004; 15:1983–1992. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous
